LONG-TERM SAFETY AND TOLERABILITY OF INHALED TREPROSTINIL IN PATIENTS WITH PULMONARY HYPERTENSION ASSOCIATED WITH INTERSTITIAL LUNG DISEASE

被引：1
|
作者：
Waxman, Aaron B.
Elwing, Jean M.
Melendres-Groves, Lana
Risbano, Michael G.
Lenneman, Andrew J.
Tapson, Victor F.
Shen, Eric
Smith, Peter
Deng, C. Q.
Nathan, Steven D.
机构：
来源：
CHEST | 2022年 / 162卷 / 04期
关键词：
D O I：
10.1016/j.chest.2022.08.1924
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：2330A / 2332A
页数：3
相关论文
共 50 条
  • [1] Efficacy, safety, and pharmacokinetics of inhaled treprostinil in Japanese patients with pulmonary hypertension associated with interstitial lung disease
    Sakao, Seiichiro
    Kondoh, Yasuhiro
    Kinoshita, Hideyuki
    Nishiyama, Osamu
    Ogo, Takeshi
    Tanabe, Nobuhiro
    Minatsuki, Shun
    Nakayama, Kazuhiko
    Taniguchi, Yu
    Takahashi, Kenta
    Takatsu, Masahiro
    Ogura, Takashi
    [J]. RESPIRATORY INVESTIGATION, 2024, 62 (06) : 980 - 986
  • [2] Safety and tolerability of inhaled treprostinil with phosphodiesterase-5 inhibitors in patients with pulmonary hypertension due to interstitial lung disease
    Zisman, David
    Dubrock, Hilary
    King, Christopher
    Weaver, Sheila
    Nathan, Steven
    Rahaghi, Franck
    Kim, Hyoshin
    Rao, Youlan
    Shen, Eric
    Waxman, Aaron
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [3] The safety and tolerability of inhaled treprostinil in patients with pulmonary hypertension and chronic obstructive pulmonary disease
    Bajwa, Abubakr A.
    Shujaat, Adil
    Patel, Minal
    Thomas, Colleen
    Rahaghi, Franck
    Burger, Charles D.
    [J]. PULMONARY CIRCULATION, 2017, 7 (01) : 82 - 88
  • [4] Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease
    Waxman, Aaron
    Restrepo-Jaramillo, Ricardo
    Thenappan, Thenappan
    Ravichandran, Ashwin
    Engel, Peter
    Bajwa, Abubakr
    Allen, Roblee
    Feldman, Jeremy
    Argula, Rahul
    Smith, Peter
    Rollins, Kristan
    Deng, Chunqin
    Peterson, Leigh
    Bell, Heidi
    Tapson, Victor
    Nathan, Steven D.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (04): : 325 - 334
  • [5] COMPARISON OF EFFECTS OF INHALED TREPROSTINIL ON LUNG FUNCTION IN PATIENTS WITH PULMONARY HYPERTENSION ASSOCIATED WITH INTERSTITIAL LUNG DISEASE AND PULMONARY ARTERIAL HYPERTENSION
    Nathan, Steven
    Tapson, Victor
    Ramani, Gautam
    Medarov, Boris
    Levine, Deborah
    Burger, Charles
    El-Kersh, Karim
    Shen, Eric
    Rao, Youlan
    Smith, Peter
    Waxman, Aaron
    [J]. CHEST, 2021, 160 (04) : 2244A - 2246A
  • [6] Inhaled Treprostinil in Pulmonary Hypertension Associated with Lung Disease
    Faria-Urbina, Mariana
    Oliveira, Rudolf K. F.
    Agarwal, Manyoo
    Waxman, Aaron B.
    [J]. LUNG, 2018, 196 (02) : 139 - 146
  • [7] Inhaled Treprostinil in Pulmonary Hypertension Associated with Lung Disease
    Mariana Faria-Urbina
    Rudolf K. F. Oliveira
    Manyoo Agarwal
    Aaron B. Waxman
    [J]. Lung, 2018, 196 : 139 - 146
  • [8] Long-term inhaled treprostinil for pulmonary hypertension due to interstitial lung disease: INCREASE open-label extension study
    Waxman, Aaron
    Restrepo-Jaramillo, Ricardo
    Thenappan, Thenappan
    Engel, Peter
    Bajwa, Abubakr
    Ravichandran, Ashwin
    Feldman, Jeremy
    Case, Amy Hajari
    Argula, Rahul G.
    Tapson, Victor
    Smith, Peter
    Deng, Chunqin
    Shen, Eric
    Nathan, Steven D.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2023, 61 (06)
  • [9] Inhaled Treprostinil in Pulmonary Hypertension in the Context of Interstitial Lung Disease: A Success, Finally
    Behr, Juergen
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205 (02) : 144 - 146
  • [10] Is Higher Dose of Inhaled Treprostinil Truly Superior to Lower Dose of Inhaled Treprostinil in Patients With Pulmonary Hypertension Associated With Interstitial Lung Diseases?
    Genecand, Leon
    Lador, Frederic
    Montani, David
    Perneger, Thomas
    [J]. CHEST, 2024, 165 (05) : e161 - e161
12345